Infection of human primary hepatocytes with dengue virus serotype 2

Journal of Medical Virology

Volumn 79, Issue 3, 2007, Pages 300-307

  Suksanpaisan, Lukkana ^a   Cabrera Hernandez, Arturo ^a   Smith, Duncan R ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cytokine; Flavivirus; IL 8; Liver

Indexed keywords

BETA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIVER ENZYME; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE VIRUS; DENGUE VIRUS SEROTYPE 2; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GENE EXPRESSION; HEPATOMEGALY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER HISTOLOGY; LIVER NECROSIS; NONHUMAN; PROGENY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; UPREGULATION; VIRUS PLAQUE;

CELLS, CULTURED; CYTOKINES; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; PLAQUE ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP; FLAVIVIRUS;

EID: 33846785137     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20798     Document Type: Article

References (53)

1. Abdallah BM, Stilgren LS, Nissen N, Kassem M, Jorgensen HR, Abrahamsen B. 2005. Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures. Calcif Tissue Int 76:90-97.
2. Ashkenazi A, Dixit VM. 1999. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260.
3. Bhamarapravati N. 1989. Hemostatic defects in dengue hemorrhagic fever. Rev Infect Dis 11:S826-S829.
4. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL. 2002. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 76:5588-5597.
5. Chang GJ. 1997. Molecular biology of dengue viruses. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever. Wallingford: CAB International. pp 175-198.
6. Chaturvedi UC, Elbishbishi EA, Agarwal R, Mustafa AS. 2001. Cytotoxic factor-autoantibodies: Possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol Med Microbiol 30:181-186.
7. Chen HC, Lai SY, Sung JM, Lee SH, Lin YC, Wang WK, Chen YC, Kao CL, King CC, Wu-Hsieh BA. 2004. Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus. J Med Virol 73:419-431.
8. Chiba K, Zhao W, Chen J, Wang J, Cui HY, Kawakami H, Miseki T, Satoshi H, Tanaka J, Asaka M, Kobayashi M. 2004. Neutrophils secrete MIP-1 beta after adhesion to laminin contained in basement membrane of blood vessels. Br J Haematol 127:592-597.
9. Couvelard A, Marianneau P, Bedel C, Drouet MT, Vachon F, Henin D, Deubel V. 1999. Report of a fatal case of dengue infection with hepatitis: Demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum Pathol 30:1106-1110.
10. Dumoulin FL, Altfeld M, Rockstroh JK, Leifeld L, Sauerbruch T, Spengler U. 1999. Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment. J Immunol Methods 224:61-67.
11. French LE, Tschopp J. 1999. The TRAIL to selective tumor death. Nat Med 5:146-147.
12. Gagnon SJ, Ennis FA, Rothman AL. 1999. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol 73:3623-3629.
13. Gura T. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277:768.
14. Guzman MG, Kouri G. 2002. Dengue: An update. Lancet Infect Dis 2:33-42.
15. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: A pathogenetic cascade. Rev Infect Dis 11:S830-S839.
16. Henchal EA, Gentry MK, McCown JM, Brandt WE. 1982. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 31:830-836.
17. Huerre MR, Lan NT, Marianneau P, Hue NB, Khun H, Hung NT, Khen NT, Drouet MT, Huong VT, Ha DQ, Buisson Y, Deubel V. 2001. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch 438:107-115.
18. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189:1411-1418.
19. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR, Strom SC. 2000. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564-567.
20. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. 1992. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 47:265-270.
21. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30:545-551.
22. Li K, Chen Z, Kato N, Gale M, Jr., Lemon SM. 2005. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280:16739-16747.
23. Lin YL, Liu CC, Chuang JI, Lei HY, Yeh TM, Lin YS, Huang YH, Liu HS. 2000a. Involvement of oxidative stress, NF-IL-6, and RANTES expression in dengue-2-virus-infected human liver cells. Virology 276:114-126.
24. Lin YL, Liu CC, Lei HY, Yeh TM, Lin YS, Chen RM, Liu HS. 2000b. Infection of five human liver cell lines by dengue-2 virus. J Med Virol 60:425-431.
25. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, Yang TI, Sheu FC, Kuo CF, Lin YS. 2001. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol 63:143-149.
26. Lin CF, Lei HY, Shiau AL, Liu HS, Yeh TM, Chen SH, Liu CC, Chiu SC, Lin YS. 2002. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J Immunol 169:657-664.
27. Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 69:82-90.
28. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. 2004. Dengue viral infections. Postgrad Med J 80:588-601.
29. Mantovani A, Bussolino F, Dejana E. 1992. Cytokine regulation of endothelial cell function. FASEB J 6:2591-2599.
30. Marianneau P, Cardona A, Edelman L, Deubel V, Despres P. 1997. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J Virol 71:3244-3249.
31. Marianneau P, Flamand M, Deubel V, Despres P. 1998. Induction of programmed cell death (apoptosis) by dengue virus in vitro and in vivo. Acta Cient Venez 49:13-17.
32. Marianneau P, Steffan AM, Royer C, Drouet MT, Jaeck D, Kirn A, Deubel V. 1999. Infection of primary cultures of human Kupffer cells by dengue virus: No viral progeny synthesis, but cytokine production is evident. J Virol 73:5201-5206.
33. Matsuda T, Almasan A, Tomita M, Tamaki K, Saito M, Tadano M, Yagita H, Ohta T, Mori N. 2005. Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol 86:1055-1065.
34. Medin CL, Fitzgerald KA, Rothman AL. 2005. Dengue virus non-structural protein NS5 induces interleukin-8 transcription and secretion. J Virol 79:11053-11061.
35. Mohan B, Patwari AK, Anand VK. 2000. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 46:40-43.
36. Nguyen TL, Nguyen TH, Tieu NT. 1997. The impact of dengue haemorrhagic fever on liver function. Res Virol 148:273-277.
37. Nordskog BK, Fields WR, Hellmann GM. 2005. Kinetic analysis of cytokine response to cigarette smoke condensate by human endothelial and monocytic cells. Toxicology 212:87-97.
38. Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, Abanes F, Cruz DJ, Matias RR, Matsuura H, Hasebe F, Tanimura S, Kumatori A, Morita K, Natividad FF, Nagatake T. 2003. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol 71:259-264.
39. Paes MV, Pinhao AT, Barreto DF, Costa SM, Oliveira MP, Nogueira AC, Takiya CM, Farias-Filho JC, Schatzmayr HG, Alves AM, Barth OM. 2005. Liver injury and viremia in mice infected with dengue-2 virus. Virology 338:236-246.
40. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A, 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690.
41. Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom S, Sittisombut N, Malasit P. 2003. Production of anti-dengue NS1 monoclonal antibodies by DNA immunization. J Virol Methods 109:55-61.
42. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R, Kapoor S, Misra A, Mathur A, Nusrat H, Azizieh F, Khan MA, Mustafa AS. 1998. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56:280-285.
43. Remick DG. 2005. Interleukin-8. Crit Care Med 33:S466-S467.
44. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M. 1998. APO2 ligand: A novel lethal weapon against malignant glioma? FEBS Lett 427:124-128.
45. Rosen L, Khin MM, Tin U. 1989. Recovery of virus from the liver of children with fatal dengue: Reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 140:351-360.
46. Rosen L, Drouet MT, Deubel V. 1999. Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg 61:720-724.
47. Subramanian V, Shenoy S, Joseph AJ. 2005. Dengue hemorrhagic fever and fulminant hepatic failure. Dig Dis Sci 50:1146-1147.
48. Suksanpaisan L, Smith DR. 2003. Analysis of saturation binding and saturation infection for dengue serotypes 1 and 2 in liver cells. Intervirology 46:50-55.
49. Thongtan T, Panyim S, Smith DR. 2004. Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B. J Med Virol 72:436-444.
50. Wahid SF, Sanusi S, Zawawi MM, Ali RA. 2000. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health 31:259-263.
51. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163.
52. White DO, Fenner FJ. 1994. Flaviviridae. Medical virology, 4th edn. San Diego. pp 433-450.
53. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, et al. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682.